Compare VVX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVX | LMAT |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | 16200 | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2014 | 2006 |
| Metric | VVX | LMAT |
|---|---|---|
| Price | $66.77 | $107.70 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $69.50 | ★ $105.80 |
| AVG Volume (30 Days) | ★ 451.4K | 224.2K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ 126.85 | 30.57 |
| EPS | 2.45 | ★ 2.52 |
| Revenue | ★ $4,480,038,000.00 | $249,602,000.00 |
| Revenue This Year | $7.21 | $13.66 |
| Revenue Next Year | $5.52 | $8.97 |
| P/E Ratio | ★ $28.60 | $42.27 |
| Revenue Growth | 3.65 | ★ 13.53 |
| 52 Week Low | $42.09 | $71.42 |
| 52 Week High | $75.00 | $115.33 |
| Indicator | VVX | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 43.92 | 65.01 |
| Support Level | $64.36 | $81.80 |
| Resistance Level | $71.40 | $115.33 |
| Average True Range (ATR) | 3.11 | 4.54 |
| MACD | -0.52 | 0.06 |
| Stochastic Oscillator | 10.53 | 71.54 |
V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.